Mirae Asset Global Investments Co. Ltd. Raises Holdings in The Clorox Company (NYSE:CLX)

Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 99.8% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 45,813 shares of the company’s stock after acquiring an additional 22,882 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Clorox were worth $7,136,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Choreo LLC boosted its holdings in Clorox by 12.8% during the 4th quarter. Choreo LLC now owns 5,741 shares of the company’s stock valued at $819,000 after acquiring an additional 652 shares during the period. abrdn plc raised its position in Clorox by 20.1% during the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock valued at $28,268,000 after purchasing an additional 33,135 shares during the last quarter. Savoir Faire Capital Management L.P. raised its position in Clorox by 61.8% during the 4th quarter. Savoir Faire Capital Management L.P. now owns 65,192 shares of the company’s stock valued at $9,296,000 after purchasing an additional 24,897 shares during the last quarter. Game Plan Financial Advisors LLC bought a new position in Clorox during the 1st quarter valued at approximately $1,025,000. Finally, Banque Cantonale Vaudoise raised its position in Clorox by 78.2% during the 1st quarter. Banque Cantonale Vaudoise now owns 29,335 shares of the company’s stock valued at $4,492,000 after purchasing an additional 12,872 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Evercore ISI lowered their price target on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research report on Wednesday, May 1st. UBS Group decreased their target price on Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Citigroup decreased their target price on Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Morgan Stanley reissued an “equal weight” rating and issued a $160.00 target price on shares of Clorox in a research report on Tuesday, March 26th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research report on Wednesday, April 17th. Five research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company’s stock. Based on data from MarketBeat, Clorox has a consensus rating of “Hold” and an average target price of $145.33.

Read Our Latest Stock Report on Clorox

Clorox Stock Performance

Shares of CLX opened at $131.85 on Wednesday. The business’s fifty day simple moving average is $134.97 and its two-hundred day simple moving average is $143.35. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.14. The company has a market cap of $16.37 billion, a price-to-earnings ratio of 68.32, a P/E/G ratio of 1.98 and a beta of 0.39.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. The firm had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The company’s revenue for the quarter was down 5.3% on a year-over-year basis. During the same period last year, the business posted $1.51 EPS. Research analysts anticipate that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.